After being absorbed, drugs distribute in the body in part to reach target tissues, in part to be
disposed in tissues where they do not exert clinically-relevant effects. Therapeutically …

Cutaneous and visceral leishmaniasis are amongst the most devastating infectious diseases
of our time, affecting millions of people worldwide. The treatment of these serious diseases …

Leishmaniasis is a neglected tropical disease that affects about 350 million individuals
worldwide. The protozoan parasite has a relatively simple life cycle with two principal …

Visceral leishmaniasis remains a public health problem worldwide. This illness was
included by the World Health Organization in the list of neglected tropical diseases targeted …

Limited therapeutic options in visceral leishmaniasis (VL) make the treatment of this
neglected disease very challenging. In addition to this, long treatment duration and toxic …

Nanoparticles have emerged as a boon for the public health applications such as drug
delivery, diagnostic, and imaging. Biodegradable and non-bio degradable nanoparticles …

Nanotechnology is expected to be promising in many fields of medical applications, mainly
in cancer treatment. While a large number of very attractive exploitations open up for the …

Objectives This study describes the antileishmanial efficacy of the novel drug formulation of
amphotericin B (AmB) attached to functionalized carbon nanotubes (f-CNTs) and compares …

Nanomedicine seeks to manufacture drugs and other biologically relevant molecules that
are packaged into nanoscale systems for improved delivery. This includes known drugs …

There are very few drug delivery systems that target key organs via the oral route, as oral
delivery advances normally address gastrointestinal drug dissolution, permeation, and …